» Articles » PMID: 37375533

Oral Epithelial Cells Expressing Low or Undetectable Levels of Human Angiotensin-Converting Enzyme 2 Are Susceptible to SARS-CoV-2 Virus Infection In Vitro

Overview
Journal Pathogens
Date 2023 Jun 28
PMID 37375533
Authors
Affiliations
Soon will be listed here.
Abstract

The oral cavity is thought to be one of the portals for SARS-CoV-2 entry, although there is limited evidence of active oral infection by SARS-CoV-2 viruses. We assessed the capacity of SARS-CoV-2 to infect and replicate in oral epithelial cells. Oral gingival epithelial cells (hTERT TIGKs), salivary gland epithelial cells (A-253), and oral buccal epithelial cells (TR146), which occupy different regions of the oral cavity, were challenged with replication-competent SARS-CoV-2 viruses and with pseudo-typed viruses expressing SARS-CoV-2 spike proteins. All oral epithelial cells expressing undetectable or low levels of human angiotensin-converting enzyme 2 (hACE2) but high levels of the alternative receptor CD147 were susceptible to SARS-CoV-2 infection. Distinct viral dynamics were seen in hTERT TIGKs compared to A-253 and TR146 cells. For example, levels of viral transcripts were sustained in hTERT TIGKs but were significantly decreased in A-253 and TR146 cells on day 3 after infection. Analysis of oral epithelial cells infected by replication-competent SARS-CoV-2 viruses expressing GFP showed that the GFP signal and SARS-CoV-2 mRNAs were not evenly distributed. Furthermore, we found cumulative SARS-CoV-2 RNAs from released viruses in the media from oral epithelial cells on day 1 and day 2 after infection, indicating productive viral infection. Taken together, our results demonstrated that oral epithelial cells were susceptible to SARS-CoV-2 viruses despite low or undetectable levels of hACE2, suggesting that alternative receptors contribute to SARS-CoV-2 infection and may be considered for the development of future vaccines and therapeutics.

Citing Articles

The Antiviral Activity of the Lectin Griffithsin against SARS-CoV-2 Is Enhanced by the Presence of Structural Proteins.

Bains A, Fischer K, Guan W, LiWang P Viruses. 2023; 15(12).

PMID: 38140693 PMC: 10747160. DOI: 10.3390/v15122452.

References
1.
Nehlmeier I, Kempf A, Arora P, Cossmann A, Dopfer-Jablonka A, Stankov M . Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage. Cell Mol Immunol. 2023; 20(8):969-971. PMC: 10165563. DOI: 10.1038/s41423-023-01030-z. View

2.
Callaway E . Coronavirus variant XBB.1.5 rises in the United States - is it a global threat?. Nature. 2023; 613(7943):222-223. DOI: 10.1038/d41586-023-00014-3. View

3.
Nguyen N, Houhamdi L, Hoang V, Delerce J, Delorme L, Colson P . SARS-CoV-2 reinfection and COVID-19 severity. Emerg Microbes Infect. 2022; 11(1):894-901. PMC: 8942490. DOI: 10.1080/22221751.2022.2052358. View

4.
Daly J, Simonetti B, Klein K, Chen K, Kavanagh Williamson M, Anton-Plagaro C . Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020; 370(6518):861-865. PMC: 7612957. DOI: 10.1126/science.abd3072. View

5.
Bayati A, Kumar R, Francis V, McPherson P . SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J Biol Chem. 2021; 296:100306. PMC: 7816624. DOI: 10.1016/j.jbc.2021.100306. View